Key Events This Week
2 Feb: Stock hits all-time low at Rs.0.20 but surges intraday by 9.52%
3 Feb: Continues rally with 8.7% intraday surge
4 Feb: Extends gains with 8.0% intraday rise
6 Feb: Week closes at Rs.0.25, up 25.00% for the week
Feb 12
BSE+NSE Vol: 12005774
Pharmaceuticals & Biotechnology
INR 45 Cr (Micro Cap)
3.00
33
0.00%
0.80
7.29%
0.23
Murae Organisor for the last several years.
2 Feb: Stock hits all-time low at Rs.0.20 but surges intraday by 9.52%
3 Feb: Continues rally with 8.7% intraday surge
4 Feb: Extends gains with 8.0% intraday rise
6 Feb: Week closes at Rs.0.25, up 25.00% for the week

Murae Organisor Ltd is rated Sell by MarketsMOJO, with this rating last updated on 25 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 06 February 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trend, and technical outlook.
Read full news article
Murae Organisor Ltd recorded a robust intraday performance on 4 Feb 2026, surging 8.0% to hit its day high amid a broader market recovery. The stock outpaced the Sensex, which gained a modest 0.14%, reflecting significant buying momentum within the Pharmaceuticals & Biotechnology sector.
Read full news articleIntimation of adjournment of the AGM due to Lack of Quorum
Intimation of Adjournment of the 13th Annual General Meeting of the Company due to lack of Quorum
Murae Organisor Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/10/2025 inter alia to consider and approve Intimation of Board meeting of the company scheduled to be held on 11th October 2025
No Upcoming Board Meetings
No Dividend history available
Murae Organisor Ltd has announced 1:2 stock split, ex-date: 11 Jun 25
Murae Organisor Ltd has announced 1:1 bonus issue, ex-date: 09 Aug 21
Murae Organisor Ltd has announced 1:3 rights issue, ex-date: 19 Dec 24
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
None
Ifl Enterprises Limited (6.38%)
75.04%
QoQ Growth in quarter ended Jun 2025 is -99.23% vs 83.43% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is 161.05% vs -28.93% in Mar 2025
Growth in half year ended Mar 2021 is -94.26% vs 43.04% in Sep 2020
Growth in half year ended Mar 2021 is 205.92% vs -258.33% in Sep 2020
YoY Growth in year ended Mar 2025 is 33,554.33% vs -83.01% in Mar 2024
YoY Growth in year ended Mar 2025 is 14,940.00% vs -97.47% in Mar 2024